Correlation between the HBsAg Level and the Peripheral Blood Lymphocytes Profile in Chronic Hepatitis B Patients from Malaysia
AuthorsQabas Neamah Hadi, Mohammed Imad Al-Deen Mustafa, KhairulAzhar Jaafar and Hui Yee Chee
JournalSciTechnol / Virology & Antiviral Research
J Virol Antivir Res 5:2. doi:10.4172/2324-8955.100015
AbstractIn recent times, the hepatitis B virus surface antigen (HBsAg) level, a cheaper marker compared to the molecular method, has been used not only for indicating active hepatitis B virus (HBV) infection, but also for predicting the clinical and treatment outcomes. Chronic HBV (CHB) infection is related to defects in cells-mediated immunity; however, data linking the level of HBsAg with changes of immune response during a CHB infection is still lacking in Malaysia. Therefore, the aim of this study was to quantify the HBsAg level in CHB patients and to investigate its correlation with the immune status.
Materials and methods:
A total of 50 patients with CHB infection and 20 healthy controls were recruited for this cross-sectional study. Serological and biochemical analyses were performed on the serum samples. The HBV genotype was determined by direct sequencing and the viral load in the serum was measured using qPCR. The immunophenotype profiles of the peripheral blood lymphocyte were analyzed using flow cytometry and the HBsAg concentration was measured using Roche’s Elecsys HBsAg II assay.
Results:
The analyzed data demonstrated a narrowly higher mean level of bilirubin and liver enzymes exhibited by the viremic CHB patients compared to the healthy controls. In the viral load study, 15 patients had a high viral DNA load (≥ 3×106 genome copies/ mL), while 35 patients had a low or undetectable viral load (< 3×106 genome copies/mL). The phylogenetic tree analysis for 35 detectable samples elucidated that the genotypes were B and C, and they were at equal prevalence rates. The outcome of the peripheral blood lymphocyte study revealed that the percentages of CD4+ and CD8+ cells were significantly reduced, while the CD4+/CD8+ ratio were observed to be slightly increased in the CHB patients compared to the healthy controls. At the same time, there were no statistically significant differences between the CHB patients and healthy controls with respect to other peripheral blood lymphocyte cells. More than half of the patients had HBsAg titre above 1000 IU/mL, and there was a positive and negative correlation between the HBsAg titre and the percentage of total T cell lymphocytes and natural killer cells, respectively.
Conclusion:
Our findings indicated that serum HBsAg suppressednatural killer cells population, but enhanced total T cells lymphocyte in response to CHB infection. This study has shown the importance of quantitative HBsAg as a laboratory biomarker that may help to define the immune state of CHB patients
Correlation between HBsAg quantification and HBV genotypes In Chronic HBV infections
AuthorsQabas Neamah Hadi, Mohammed Imad Al-Deen Mustafa, Hui Yee Chee, KhairulAzhar Jaafar
JournalInternational Journal of Advances in Science, Engineering and Technology/IJASEAT
AbstractAccumulated data has been proposed that viral genotypes and sub genotypesplay an important role in clinical
outcome and antiviral monitoring of chronic HBV infection. Genotyping and quantitating of HBV DNA levels molecularly
is relatively expensive. On the other side, serum HBsAg quantification has been recently standardized by automated
quantitative assays leading to revived interest in the clinical utilization of this marker for diagnosis using sensitive and
reliable commercial assays. Several studies have referred to the kinetics of HBsAg to predict response to antiviral therapy.
Thus, a cheaper laboratory test as a surrogate diagnostic marker might simplify patients’ management. Objectives: to
evaluate whether quantitative HBsAg levels correlate with HBV genotypes in Malaysian CHB patients. Patients and
Methods: In this cross-sectional study, fifty serum samples from patients with hepatitis B were used, however those tested
positive for antibodies to HCV and HDV were excluded. The serum HBsAg level was quantified by Elecsysassay. In
addition, HBV DNA load was measured by real-time polymerase chain reaction whereas identification of HBV genotypes
was done by direct sequencing. Results: Of 50 patients, 31 were males (44%) and 19 females (27%); the mean age was37 ±
12 years. Forty-two (42) patients had HBsAg level >100 IU/mL.Eightypercent (40) were HBeAg-negative while 20% (10)
were positive. Genotyping showed that 22 patients had genotype C (44%), and 18 patients were of genotype B (36%).
Applying Mann-Whitney test, HBs Agtiters correlated differentially with HBV genotypes C& B. (p<0.05). By Nonparametric
T test, there was no significant correlation between HBsAg levels and HBV DNA levels (p<0.05).Conclusions:
the statistically significant association between levels of HBsAg and HBV genotypes was observed especially for genotype
C. Hence, HBsAg level could be a useful serological marker to predict the genotypes B and C of HBV and thus possibly
anticipate the response to treatment with antiviral drugs.
Alteration of Peripheral Blood Lymphocytes (PBLs) profile with HBsAg level in patients with chronic hepatitis B infection
AuthorsHadi, Qabas Naemah, Mohammed Imad Al-Deen Mustafa, Hui Yee Chee, Khairul Azhar Joafar, and Yaollah Abolfathi Momtaz
JournalInternational Conference on Biological, Chemical and Environmental Sciences ( IICBE
AbstractChronic hepatitis B infection is associated with
dysfunction of cell- mediated immunity. Little is known about the
changes of immune response during chronic hepatitis B infection,
particularly in correlation between sequential alterations in peripheral
blood immune cells population and hepatitis B surface antigen
(HBsAg). AIM: to examine the dynamic changes in the population of
peripheral blood lymphocyte (PBL) subsets (T cells subsets, B
lymphocytes, and NK cells) in healthy donors and patients with
CHBI and their correlation with the level of HBsAg (qHBsAg).
METHODS: the immunophenotype profiles of PBL of 50(HCV,
HDV and HIV negative) chronic hepatitis B patients and 25 healthy
controls were analyzed by Flowcytometry (FCM). In addition the
serum HBeAg status was determined by ELISA and the HBsAg level
was quantified by Elecsys assay (Roche Diagnostics, Germany).
Results: significant reduction in both the percentages of
CD4+(p≤0.05), CD8+ T lymphocyte subsets and the CD4+/ CD8+
ratio (p<0.01) was found in chronic hepatitis B patients as compared
with the healthy donors. Meanwhile, there were no significant
differences between patients and healthy controls with regard to other
PBL parameters (total T, B, and NK cells), but a significant
correlation was observed between HBsAg level and the percentages
of T and NK cells (r=0.366; p<0.01, r=-0.462; p<0.05) respectively.
Conclusion: our findings confirmed that CHB patients may have
adversely affected cell-mediated immunity which is significantly
correlated with a higher HBsAg level that leading to progress of the
disease these patients